Notebook

Who Says Science Can't Be Fun? Playing The Odds Sign Of The Times Bridging The Gap The Invisible Professor The organizers of next month's annual meeting of the Association of Science-Technology Centers in Orlando, Fla., have made a bold bid to boost attendance by including in the registration packet a one-day pass for three popular theme parks in the area -- Universal Studios, EPCOT Center, and Sea World. The ploy is one way for ASTC, an association of more than 300 museums and affiliated insti

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Having trouble getting NSF to fund your research grant? Sponsor a conference instead. Responding to widespread rumors that funding rates were as low as 10 to 15 percent, NSF's Pat Werner and Jim Edwards analyzed the proposals funded by the Division of Biotic Systems and Resources, which gives out grants in ecology, population biology, and systematics. Not true, they discovered: The lowest success rate for investigator-initiated research funded by any one program was 19.7 percent, and the average was near the foundation's overall rate of 25 percent. At the same time, the program managers found that conferences and professional travel were the surest paths to success. In fact, approval rates in some sections topped 80 percent. To be sure, the competition was quite a bit easier: The division received 1,316 research proposals last year, compared with just 38 requests for conferences and travel. The latter are popular with budget-conscious program ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies